Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Zydus Lifesciences Limited
Press Release Jul 24 2025
Business
Jul 24 2025
3 min read

Press Release Jul 24 2025

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 24, 2025, titled "Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg".

View Attachment